— Know what they know.
Not Investment Advice
Also trades as: 0M3O.L (LSE)

ZGNX NASDAQ

Zogenix, Inc.
1W: +2.2% 1M: +2.1% 3M: +114.0% 1Y: +28.6% 3Y: -47.6% 5Y: +169.5%
$26.68
Last traded 2022-03-04 — delisted
NASDAQ · Healthcare · Biotechnology

Balance Sheet Trends

Total Assets
$468M -28.0% ▼
5Y CAGR: +15.1%
Total Liabilities
$290M +2.9% ▲
5Y CAGR: +21.2%
Shareholders Equity
$179M -51.6% ▼
5Y CAGR: +8.2%
Cash & Investments
$302M -40.3% ▼
5Y CAGR: +26.9%
Total Debt
$168M +11.5% ▲
5Y CAGR: +50.1%
Net Debt
$67M +523.9% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2017FY2018FY2019FY2020FY2021
— Assets —
Cash$294M$68M$62M$167M$101M
Short-Term Investments$0$446M$189M$338M$201M
Cash & ST Investments$294M$514M$251M$505M$302M
Net Receivables$0$0$0$4M$10M
Inventory$0$0$0$1M$5M
Other Current Assets$11M$19M$36M$12M$37M
Total Current Assets$305M$533M$287M$522M$355M
Property, Plant & Equip.$245K$3M$17M$16M$14M
Goodwill & Intangibles$109M$109M$109M$105M$97M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$4M$4M$1M$8M$3M
Total Non-Current Assets$113M$116M$127M$129M$114M
Total Assets$418M$648M$414M$651M$468M
— Liabilities —
Accounts Payable$3M$8M$8M$12M$22M
Short-Term Debt$0$0$1M$2M$2M
Deferred Revenue$0$0$6M$5M$5M
Other Current Liabilities$18M$50M$80M$64M$69M
Total Current Liabilities$21M$58M$95M$83M$98M
Long-Term Debt$0$0$0$149M$167M
Other Non-Current Liab.$78M$50M$49M$44M$22M
Total Non-Current Liabilities$95M$67M$74M$199M$192M
Total Liabilities$116M$126M$169M$281M$290M
— Equity —
Common Stock$35K$42K$45K$56K$56K
Retained Earnings-$572M-$696M-$1.1B-$1.3B-$1.6B
Accumulated OCI-$1M$3K$379K-$71K$15K
Total Stockholders Equity$302M$523M$245M$370M$179M
Total Liabilities & Equity$418M$648M$414M$651M$468M
— Key Metrics —
Total Debt$0$0$12M$151M$168M
Net Debt-$294M-$68M-$50M-$16M$67M
Total Investments$0$446M$189M$338M$201M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms